Abbott Laboratories
ABT
NYSE
Last Updated: 12/1/2023 9:00:02 PM
High
Low
About Abbott Laboratories
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.Abbott Laboratories Company Details
CEO: Mr. Robert B. Ford
Country: US
Industry: Medical Devices
Website: https://www.abbott.com
Exchange: New York Stock Exchange
IPO\Launch Date: 1980-03-17
Abbott Laboratories Company Executive Details
Mr. Robert E. Funck Jr.
Executive Vice President of Fin.
Mr. Robert E. Funck Jr.
Executive Vice President of Finance
Mr. Philip P. Boudreau
Chief Financial Officer & Senior Vice President of Fin.
Mr. Hubert L. Allen
Executive Vice President, General Counsel & Secretary
Mr. Daniel Gesua Sive Salvadori
Executive Vice President and Group President of Established Pharmaceuticals & Nutritional Products
Abbott Laboratories Latest News
Abbott Laboratories: A 'Must-Have' In A Defensive Dividend Growth Portfolio
In 2023, AI and the Magnificent 7 took the lead, leaving non-tech blue chip companies trailing behind in the rearview mirror. Abbott Laboratories had a difficult last three years, with its stock price trading sideways as sales driven by COVID-19 plummeted. Yet, Abbott operates a recession-proof business model with long-term tailwinds, its core business growing at double digits.
Published on: 2023-12-03 04:00:32
Impact on Symbol / Company: ABT
View News
Abbott (ABT) Rises Higher Than Market: Key Facts
Abbott (ABT) closed the most recent trading day at $104.29, moving +0.64% from the previous trading session.
Published on: 2023-11-30 19:32:35
Impact on Symbol / Company: ABT
View News
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
Published on: 2023-11-28 10:31:54
Impact on Symbol / Company: ABT
View News
Here's Why Investors Should Retain Abbott (ABT) Stock Now
Investors are optimistic about Abbott (ABT) driven by expansion in the global market and raised guidance.
Published on: 2023-11-27 14:17:22
Impact on Symbol / Company: ABT
View News
Abbott Laboratories: One Of The Safest Dividend Growth Stocks On The Market
Abbott Laboratories is a stable investment in challenging times, with an AA- credit rating and a history of surviving economic downturns. ABT has a well-diversified healthcare portfolio, including diagnostics, medical devices, and pharmaceuticals, positioning it to address evolving healthcare challenges. Despite a temporary stock dip, ABT has shown robust financial performance with impressive growth across segments, reflecting resilience and sales expansion.
Published on: 2023-11-25 21:57:07
Impact on Symbol / Company: ABT
View News
PETQ vs. ABT: Which Stock Should Value Investors Buy Now?
Investors with an interest in Medical - Products stocks have likely encountered both PetIQ (PETQ) and Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck right now?
Published on: 2023-11-20 12:47:13
Impact on Symbol / Company: ABT
View News
Ozempic Might Be Helping Abbott Laboratories and DexCom Stock. Here's How.
Ozempic could lead to patients needing to buy fewer interventions for diabetes. It could also do the same for certain cardiovascular interventions.
Published on: 2023-11-20 06:03:00
Impact on Symbol / Company: ABT
View News
Abbott rumored to endorse Trump during border visit
Rep. Carlos Gimenez, R-Fla., discusses former President Donald Trump's upcoming trip to Texas on 'The Evening Edit.
Published on: 2023-11-17 03:45:02
Impact on Symbol / Company: ABT
View News
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Published on: 2023-11-15 10:34:19
Impact on Symbol / Company: ABT
View News
Who's afraid of Ozempic? From restaurants to package makers, companies work to calm investors' GLP-1 jitters.
That's the message from many corporate executives who have lately been peppered with questions about how Wegovy, Ozempic and other drugs widely used for weight loss may impact their bottom line.
Published on: 2023-11-10 11:13:00
Impact on Symbol / Company: ABT
View News
15 stocks with the closest US government connections
Quiver Quantitative, the pioneering company behind an alternative data platform designed for retail investors, has been actively tracking stock market trades made by US Congress members and other political figures. Some of the trades have been notably controversial, mainly due to their timing or because they violated federal laws.
Published on: 2023-11-09 09:32:41
Impact on Symbol / Company: ABT
View News
Abbott India's Q2 profit climbs on strong sales
Abbott India , the local unit of U.S. healthcare firm Abbott Laboratories , reported a 17.7% rise in second-quarter profit on Thursday, driven by strong sales in its mainstay pharmaceuticals segment.
Published on: 2023-11-09 03:44:16
Impact on Symbol / Company: ABT
View News
Grow your Money
We helps you in understanding the science behind growing the money, which will help you diversify your funds as per your requirements and helps in achieving your retirement goals, children education, investment in property, business or any smart looking startup ventures
Services we Offer
We offer several services including expert recommendations & suggestions on buying ETF, Mutual Funds, Bonds, Debt securities, Equities, Property invesments and several others
Live Market Data
We provide you live market data for your analysis, review and looking out for quick buying opportunities to help you